![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 44, 31174-31178, October 29, 1999
From the Department of Pharmacology and Physiology, University of
Rochester School of Medicine and Dentistry,
Rochester, New York 14642
We have recently questioned whether the
capacitative or store-operated model for receptor-activated
Ca2+ entry can account for the influx of
Ca2+ seen at low agonist concentrations, such a those
typically producing [Ca2+]i
oscillations. Instead, we have identified an arachidonic acid-regulated, noncapacitative Ca2+ entry mechanism that
appears to be specifically responsible for the receptor-activated entry
of Ca2+ under these conditions. However, it is unclear
whether these two systems reflect the activity of distinct entry
pathways or simply different mechanisms of regulating a common pathway.
We therefore used the known selectivity of the
Ca2+-stimulated type VIII adenylyl cyclase for
Ca2+ entry occurring via the capacitative pathway (Fagan,
K. A., Mahey, R., and Cooper, D. M. F. (1996)
J. Biol. Chem. 271, 12438-12444) to attempt to
discriminate between these two entry mechanisms in HEK293 cells.
Consistent with the earlier reports, we found that thapsigargin induced
an approximate 3-fold increase in adenylyl cyclase activity that was
unrelated to global changes in
[Ca2+]i or to the release of
Ca2+ from internal stores but was specifically dependent on
the induced capacitative entry of Ca2+. In marked contrast,
the arachidonate-induced entry of Ca2+ completely failed to
affect adenylyl cyclase activity despite producing a substantially
greater rate of entry than that induced by thapsigargin. These data
demonstrate that the arachidonate-activated entry of Ca2+
occurs via an entirely distinct influx pathway.
The agonist-stimulated entry of extracellular Ca2+
plays a critical role in the generation and maintenance of
intracellular Ca2+
([Ca2+]i)1
signals resulting from activation of receptors coupled to the phospholipase C/inositol trisphosphate signaling pathway. However, in
nonexcitable cells, the precise nature and mechanism of activation of
such Ca2+ entry pathways remains unclear. An activation of
a Ca2+ entry that is dependent on and subsequent to the
emptying of intracellular agonist-sensitive Ca2+ stores has
been demonstrated in a wide variety of cells. This so-called
"capacitative" or store-operated mechanism of Ca2+
entry first proposed by Putney (1, 2) appears to be an almost universal
feature of cells and can be readily demonstrated to be responsible for
the sustained elevations of
[Ca2+]i following activation of
cells with high agonist concentrations, as well as for the refilling of
the agonist-sensitive stores on the termination of such signals.
Recently however, we have questioned whether the demonstrated
properties of such capacitative entry and the characteristics of the
channels involved (as far as is currently known) are adequate or
appropriate to account for the receptor-activated influx of
Ca2+ seen at low agonist concentrations, such a those that
typically give rise to oscillatory
[Ca2+]i signals (3, 4). This is an
important question for two reasons. First, it is generally considered
that such oscillatory [Ca2+]i
signals are likely to represent the physiologically relevant response
for many cells. Second, it is known that the receptor-activated influx
of Ca2+ during such signals has a marked effect on the
oscillation frequency (5-9), which is a key component of the
agonist-generated message within the cell. Our studies on the mechanism
of Ca2+ entry during
[Ca2+]i oscillations led us to the
identification of a novel noncapacitative Ca2+ entry
pathway that is gated by arachidonic acid and that appears to be
specifically responsible for the receptor-activated entry of
Ca2+ under these conditions (10, 11). Together, our studies
have shown that 1) arachidonic acid is generated at the relevant
agonist concentrations that are known to produce
[Ca2+]i oscillations in the same
cells; 2) the addition of low concentrations of exogenous arachidonic
acid induces an entry of Ca2+ that is entirely independent
of store depletion; 3) the inhibition of the agonist-induced generation
of arachidonic acid specifically and rapidly blocks the
Ca2+ entry associated with
[Ca2+]i oscillations, yet it is
without effect on capacitative Ca2+ entry; 4) inhibition of
the metabolism of arachidonic acid converts agonist-induced oscillatory
[Ca2+]i signals into sustained
"plateau" signals, as might be expected if Ca2+ entry
was further increased by the accumulating arachidonic acid (10, 11).
Based on these findings, it is our contention that arachidonic acid
fulfills all the generally accepted criteria for being the second
messenger responsible for the regulation of the agonist-activated entry
of Ca2+ during [Ca2+]i oscillations.
What is not entirely clear, however, is whether arachidonic acid is
regulating an entirely distinct Ca2+ entry pathway in the
plasma membrane or merely modulating the activity of the same pathway
activated by store depletion in the capacitative mechanism. We have
previously shown that the [Ca2+]i
signal produced by capacitative Ca2+ entry and that
produced by the addition of exogenous arachidonic acid demonstrate
differences in their sensitivity to a reduction in extracellular pH,
suggesting that they may represent distinct entry pathways (11). In the
following study, we have used the reported marked selectivity of
certain Ca2+-sensitive adenylyl cyclases in cells for
Ca2+ entering specifically via the capacitative pathway
(12). It has been shown in a variety of studies that these adenylyl
cyclases, whether endogenously present or following their transient
transfection, are largely unresponsive to changes in
[Ca2+]i resulting from
Ca2+ release from internal stores or from Ca2+
entry via "nonspecific" ionomycin-induced pathways. In contrast, these same adenylyl cyclases are acutely sensitive to the
Ca2+ entering via store-operated mechanisms (13), a
sensitivity that is believed to reflect a specific co-localization of
the adenylyl cyclase with the store-operated Ca2+ channels
in the plasma membrane (14). In this study we have utilized the type
VIII Ca2+-stimulated adenylyl cyclase transiently
transfected into HEK293 cells. This is the same adenylyl cyclase and
cell line used by Fagan et al. (13) who showed that its
activity was markedly and specifically increased by Ca2+
entering via the capacitative or store-operated pathway.
Materials--
Thapsigargin, arachidonic acid,
isobutylmethylxanthine, and
4-(3-butoxy-4-methoxyphenyl)-2-imidazolidinone were all from Biomol Research Laboratories Inc. The cyclic AMP binding assay kits were from
Amersham Pharmacia Biotech. Samples of the human embryonic kidney cell
line HEK293 were obtained from the ATCC.
Plasmid Construction and Transient Transfection--
The rat
type VIII adenylyl cyclase cDNA clone in the pcDNA3.1
expression vector (Invitrogen) was generously provided by Dr. Dermot
Cooper (University of Colorado, Denver, CO). HEK293 cells were cultured
under standard conditions in Dulbecco's modified Eagle's medium
supplemented with 10% calf serum and antibiotics at 37 °C in a
humidified atmosphere of 95% air and 5% CO2. Prior to
transfection, cells were seeded into 75-cm2 flasks and
grown until approximately 50% confluent. Transfection was performed by
the calcium phosphate method of Chen and Okayama (15) using 26 µg of
plasmid DNA. Eighteen hours after transfection, cells were washed and
then harvested using Ca2+-Mg2+-free
phosphate-buffered saline containing 0.06% EDTA. The harvested cells
were centrifuged, resuspended in medium, plated into 6-well culture
dishes, and incubated for a further 2 days before experiments were performed.
Cyclic AMP Accumulation--
Adenylyl cyclase activity in
vivo was assayed indirectly by determining the accumulation of
cAMP in cells preincubated for 10 min in the presence of the
phosphodiesterase inhibitors (500 µM
isobutylmethylxanthine, 100 µM
4-(3-butoxy-4-methoxyphenyl)-2-imidazolidinone). By eliminating the
metabolism of generated cAMP, these inhibitors allowed an estimate of
overall adenylyl cyclase activity in the intact cells. Furthermore, the
use of phosphodiesterase inhibitors eliminated any possible influence
of changes in [Ca2+]i affecting
cAMP levels as a result of influencing phosphodiesterase activities
(16, 17). Except where indicated, cAMP accumulation was determined over
a 3-min period following the addition of 10 µM forskolin.
Cellular cAMP was determined by a binding assay kit (Amersham Pharmacia
Biotech) after extraction with ice-cold 0.5 M
trichloroacetic acid followed by washing (4 times) with water-saturated
ether and neutralization with sodium bicarbonate. Values were
normalized to total cellular protein (Coomassie Blue reagent, Pierce).
Measurements of [Ca2+]i and
Mn2+ Quench--
Determinations of changes in
[Ca2+]i and rates of
Mn2+ quench used techniques modified from those previously
described (18, 19). Briefly, cells were loaded with the fluorescent probe indo-1 by incubating with 4 µM indo-1/AM for 12 min, followed by washing (three times) in saline. Cells were then
incubated for a further 30 min at 37 °C to allow for complete
hydrolysis of the acetoxymethyl ester.
[Ca2+]i was measured as described
previously (18, 19) and recorded as the ratio of the emitted
fluorescence, measured as photon counts, at 405 and 485 nm with
excitation at 350 nm. Measurements of Mn2+ quench were as
described previously (19) using the sum of the two emitted
fluorescences adjusted so as to make the result Ca2+
insensitive. Data were normalized to the initial value recorded at the
time of Mn2+ addition. In the experiments described here,
both the [Ca2+]i and
Mn2+ quench were determined as an average for small groups
of cells (approximately 30-50), thereby overcoming the potential
problems of uneven transfection.
Initially, to estimate the success and consistency of the
transfection procedure, forskolin-stimulated cAMP accumulation was determined in the parental HEK293 cells and in HEK293 cells following transient transfection with the type VIII adenylyl cyclase construct (AC8-HEK cells). The data obtained indicated that the accumulation of
cAMP in the presence of phosphodiesterase inhibitors was barely detectable in the HEK293 cells under control conditions (22.2 ± 1.4 pmol/mg protein) but rose to 490.4 ± 21.7 pmol/mg protein (n = 3) in the presence of 10 µM
forskolin presumably reflecting the activity of endogenous adenylyl
cyclases. Following transient transfection with the type VIII adenylyl
cyclase, resting cAMP accumulation was 157.2 ± 23.5 pmol/mg
protein and was stimulated approximately 15-fold to 2250.3 ± 345.8 pmol/mg (n = 7) in the presence of forskolin.
This amounts to a 4.6-fold increase in forskolin-stimulated cAMP
accumulation following transfection. These data represent the results
of separate transfections and demonstrate that reasonably consistent
levels of expression were obtained in each case.
The overall aim of the study was to compare the ability of
arachidonate-activated and store-operated (capacitative)
Ca2+ entry pathways to induce an activation of the
transfected adenylyl cyclase. We chose the sarcoplasmic-endoplasmic
reticulum calcium pump inhibitor thapsigargin as the agent to activate
the capacitative entry of Ca2+. The use of thapsigargin and
exogenous arachidonic acid to activate capacitative and noncapacitative
Ca2+ entry, respectively, avoids the potential activation
or generation of additional signaling moieties such as
G Changes in adenylyl cyclase activity during the period when
[Ca2+]i rose to its maximum values
were assessed by determining cAMP accumulation in the presence of
phosphodiesterase inhibitors and forskolin during the first 3 min after
the addition of either 8 µM arachidonic acid or 250 nM thapsigargin (Fig. 2). It
can be seen that thapsigargin produced a greater than 2.5-fold
stimulation of adenylate cyclase during this period. In marked contrast
and despite the very similar rate and magnitude of the overall increase in [Ca2+]i, arachidonic acid
failed to produce any significant increase in adenylyl cyclase
activity. This inability of the arachidonic acid-induced changes in
[Ca2+]i to effectively increase
cAMP accumulation was not due to any independent inhibitory action of
the fatty acid on the adenylyl cyclase activity as, in a separate
series of experiments, simultaneous addition of 8 µM
arachidonic acid to cells exposed to 250 nM thapsigargin
had no significant effect on the ability of the latter to increase cAMP
accumulation (7.75 ± 0.28 µmol/mg protein for thapsigargin
alone compared with 7.08 ± 0.28 µmol/mg protein for
thapsigargin in the presence of arachidonic acid, n = 5, p = 0.07).
Discriminating between Capacitative and Arachidonate-activated
Ca2+ Entry Pathways in HEK293 Cells*
and
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
s, G
i, protein kinase C, and G protein

subunits, which are known to have type-specific effects on
adenylyl cyclase activity (20). Examination of the overall
[Ca2+]i responses induced in each
case revealed that the addition of 250 nM thapsigargin to
the AC8-HEK cells produced a
[Ca2+]i signal that closely
paralleled that produced by 8 µM exogenous arachidonic
acid (Fig. 1). This
[Ca2+]i signal comprised an
initial increase to a peak value over the first approximately 150 s followed by a slow decline (equivalent to approximately 30% of the
initial increase) over the succeeding 200 s. Comparison of the
thapsigargin and arachidonic acid responses indicated a close
similarity in the rate of the initial increase, peak values attained,
and rate of subsequent slow decline. The only consistent difference was
a somewhat more rapid onset of the rise in
[Ca2+]i in the case of
thapsigargin addition. These concentrations were subsequently used in
all remaining experiments.

View larger version (20K):
[in a new window]
Fig. 1.
Comparison of the effect of thapsigargin and
arachidonic acid on [Ca2+]i levels in
AC8-HEK293. Cells loaded with indo-1 were exposed to either
thapsigargin (250 nM) or arachidonic acid (8 µM) at the point indicated by an arrow.
Changes in [Ca2+]i recorded as the
405/485 emission ratio were determined in a group of 30-50 cells as
described under "Experimental Procedures." Typical responses are
illustrated.

View larger version (16K):
[in a new window]
Fig. 2.
The effect of arachidonic acid and
thapsigargin on forskolin-stimulated adenylyl cyclase activity in
AC8-HEK293 cells. Cells were pretreated for 10 min with the
phosphodiesterase inhibitors isobutylmethylxanthine and
4-(3-butoxy-4-methoxyphenyl)-2-imidazolidinone. Where indicated,
(solid bars) 10 µM forskolin (+F)
together with 8 µM arachidonic acid (AA) or
250 nM thapsigargin (thaps) was added, and
cellular cAMP accumulation was determined 3 min later. Values are
mean ± S.E., n = 7 (6 for the thapsigargin + forskolin).
Despite the overall similarity in the
[Ca2+]i changes, it is important
to appreciate that there are marked differences in the origin of these
changes in the two situations. In the case of thapsigargin,
Ca2+ is initially released from intracellular stores as a
result of inhibition of the sarcoplasmic-endoplasmic reticulum calcium
pump on the store membranes (21). The resulting depletion of the intracellular stores subsequently activates Ca2+ entry via
a capacitative mechanism of unknown nature. In contrast, we have
previously shown that the increase in
[Ca2+]i induced by exogenous
arachidonic acid results entirely from an increased Ca2+
entry (10, 11). As stimulation of the type VIII adenylyl cyclase has
been reported to be specifically dependent on Ca2+ entry
via capacitative pathways (13) it was important to compare the effects
of thapsigargin and arachidonic acid at a time when [Ca2+]i changes were specifically
dependent on Ca2+ entry alone. Furthermore it is known
that, both in the case of thapsigargin and exogenous arachidonic acid,
activation of Ca2+ entry is rather slow to develop (11,
19). To examine the time course of the activation of Ca2+
entry in the experiments performed here, a Mn2+ quench
protocol was employed on the AC8-HEK cells. Fig.
3 illustrates the response to the
addition of 8 µM arachidonic acid. As can be seen,
although an increase in the rate of Mn2+ quench could be
detected approximately 1 min after the addition of arachidonic acid,
maximal rates were not achieved until some 2 min later. A similar time
course for the increase in the rate of Mn2+ quench was
obtained with the addition of 250 nM thapsigargin (data not
shown).
|
Based on these data we sought to examine the effects on adenylyl
cyclase activity over the period 3-6 min after addition, at which time
Ca2+ entry was at its maximum. Consistent with the reported
specific dependence of the Ca2+-sensitive adenylyl cyclase
on capacitative Ca2+ entry and with the above data on the
rates of Mn2+ quench, examination of the
thapsigargin-stimulated rate of cAMP accumulation during this period
was somewhat higher (approximately 38%) than that seen during the
first 3 min despite the observed decline in overall values of
[Ca2+]i (Fig.
4). This indicates that activation of the
adenylyl cyclase is independent of overall values of
[Ca2+]i as reported previously.
Furthermore, nominal removal of extracellular Ca2+ during
this period completely obliterated the observed thapsigargin-induced stimulation in adenylyl cyclase activity (Fig. 4). This did not reflect
an inhibitory effect of extracellular Ca2+ on the adenylyl
cyclase as activities in the absence of thapsigargin were not
significantly affected. This demonstrates that any possible contribution from Ca2+ release from intracellular stores
can be ignored at this stage of the response.
|
Comparison of the effects of thapsigargin and of arachidonic acid on
the adenylyl cyclase activity during this period of maximal increase in
Ca2+ entry (3-6 min after addition) reveals that, once
again, whereas thapsigargin induces a marked stimulation in activity
(approximately 2.5-fold), arachidonic acid completely fails to have any
influence on the adenylyl cyclase (Fig.
5A). Importantly, this
observed inability of arachidonate-induced changes in
[Ca2+]i to induce any stimulation
of adenylyl cyclase activity was not because of a lower rate of
Ca2+ entry during this period as comparison of the rates of
Mn2+ quench induced by thapsigargin (250 nM)
and exogenous arachidonic acid (8 µM) during the period
3-6 min after the addition clearly show that, in fact, the
arachidonate-induced rates of Mn2+ quench were more than
twice that seen during the same period after the addition of
thapsigargin (Fig. 5B).
|
| |
DISCUSSION |
|---|
|
|
|---|
The data obtained allow us to assess the contributions of the various components of the induced changes in [Ca2+]i to the observed stimulation of the transfected type VIII adenylyl cyclase. The reported absence of endogenous Ca2+-stimulated adenylyl cyclases in HEK293 cells (22) means that the effects observed can be ascribed exclusively to the transfected type VIII adenylyl cyclase. A major influence of general [Ca2+]i levels on the adenylyl cyclase activity can be excluded by the failure of exogenously added arachidonic acid to affect adenylyl cyclase activities. Despite very similar changes in the overall [Ca2+]i values in the thapsigargin-treated and the arachidonate-treated cells, thapsigargin produces a marked stimulation of adenylyl cyclase activity yet no increase is seen in the arachidonate-treated cells. This is further confirmed by the fact that the thapsigargin-induced stimulation of activity is significantly higher in the second 3-min period after the addition despite the obvious decline in [Ca2+]i during the same period. Furthermore, during the second 3-min period after the addition of thapsigargin, we have shown that the continued high adenylyl cyclase activity is entirely dependent on the presence of extracellular Ca2+. This clearly excludes any possible contribution from Ca2+ released from stores, at least during this period of the response. Together, these data clearly demonstrate that, at least in the thapsigargin-treated cells during the second 3-min period after addition, the adenylyl cyclase is being stimulated specifically by the entry of Ca2+. As such, these data are consistent with previous reports that the Ca2+-stimulated type VIII adenylyl cyclase (13), as with other Ca2+-sensitive adenylyl cyclases, responds particularly to the Ca2+ entry component of the overall Ca2+ signal (12, 13, 23). However, in marked contrast, the adenylyl cyclase is entirely unresponsive to the Ca2+ entry activated by arachidonic acid. This is despite the fact that, at the respective concentrations used, the rate of Ca2+ entry activated by arachidonic acid would appear to be greater than twice that induced by thapsigargin.
In the previous reports examining the Ca2+-sensitive
adenylyl cyclases in vivo, it has been clearly demonstrated
that the endogenous type VI Ca2+-inhibited adenylyl cyclase
of C6-2B glioma cells, as well as the type I and VIII
Ca2+-stimulated adenylyl cyclases transiently transfected
into HEK293 cells, respond specifically to entry via a capacitative
pathway; an even more substantial but nonspecific entry induced by
ionomycin fails to affect adenylyl cyclase activity (13, 14). A similar tight coupling between capacitative Ca2+ entry and the type
III adenylyl cyclase has been reported as underlying the potentiation
of adrenocorticotrophin-induced cAMP formation by angiotensin II (24)
and in the sustained potentiation of isoproterenol-stimulated cAMP
generation by carbachol in mouse parotid (25). In all cases, it has
been suggested that this high degree of specificity reflects an
intimate association and co-localization of the enzyme with the
capacitative channel sites in the plasma membrane. Obviously, this
tight association applies both to endogenous as well as to
heterologously expressed adenylyl cyclases. Additional experiments by
Fagan et al. (14) have shown that this association between
the adenylyl cyclase and sites of capacitative Ca2+ entry
does not involve the cytoskeleton, implying either some form of
co-compartmentalization within the plasma membrane or a direct
protein-protein interaction. The same authors also demonstrated that
the activation of the adenylate cyclase was a direct consequence of the
Ca2+ influx via the capacitative channel and not to any
conformational change associated with the channel opening. Given this
demonstrated intimate spatial relationship between capacitative
Ca2+ entry sites and the adenylyl cyclase, the complete
failure of the Ca2+ entry induced by arachidonic acid to
produce any change in adenylyl cyclase activity clearly demonstrates
that the arachidonate-induced Ca2+ entry channel must be an
entirely distinct entity from that responsible for capacitative entry.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Dermot Cooper of the University of Colorado for generously providing us with the rat type VIII adenylyl cyclase cDNA plasmid.
| |
FOOTNOTES |
|---|
* This work was supported by National Institute of General Medical Sciences Grant GM 40457.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pharmacology
and Physiology, Box 711, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642. Tel.: 716-275-2076; Fax:
716-244-9283; E-mail: tshut@pharmacol.rochester.edu.
| |
ABBREVIATIONS |
|---|
The abbreviation used is: [Ca2+]i, intracellular free calcium ion concentration.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Putney, J. W., Jr. (1986) Cell Calcium 7, 1-12[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Putney, J. W., Jr. (1990) Cell Calcium 11, 611-624[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Shuttleworth, T. J., and Thompson, J. L. (1996) Biochem J. 316, 819-824 |
| 4. | Shuttleworth, T. J. (1999) Cell Calcium 25, 237-246[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Kawanishi, T.,
Blank, L. M.,
Harootunian, A. T.,
Smith, M. T.,
and Tsien, R. Y.
(1989)
J. Biol. Chem.
264,
12859-12866 |
| 6. |
Rooney, T. A.,
Sass, E. J.,
and Thomas, A. P.
(1990)
J. Biol. Chem.
265,
10792-10796 |
| 7. |
Girard, S.,
and Clapham, D.
(1993)
Science
260,
229-232 |
| 8. | Shuttleworth, T. J., and Thompson, J. L. (1996) Biochem. J. 313, 815-819 |
| 9. | Bootman, M. D., Young, K. W., Young, J. M., Moreton, R. B., and Berridge, M. J. (1996) Biochem. J. 314, 347-354 |
| 10. |
Shuttleworth, T. J.
(1996)
J. Biol. Chem.
271,
21720-21725 |
| 11. |
Shuttleworth, T. J.,
and Thompson, J. L.
(1998)
J. Biol. Chem.
273,
32636-32643 |
| 12. | Cooper, D. M. F., Karpen, J. W., Fagan, K. A., and Mons, N. E. (1998) Adv. Second Messenger Phosphoprotein Res. 32, 23-51[Medline] [Order article via Infotrieve] |
| 13. |
Fagan, K. A.,
Mahey, R.,
and Cooper, D. M. F.
(1996)
J. Biol. Chem.
271,
12438-12444 |
| 14. |
Fagan, K. A.,
Mons, N.,
and Cooper, D. M. F.
(1998)
J. Biol. Chem.
273,
9297-9305 |
| 15. |
Chen, C.,
and Okayama, H.
(1987)
Mol. Cell. Biol.
7,
2745-2752 |
| 16. | Meeker, R. B., and Harden, T. K. (1982) Mol. Pharmacol. 22, 310-319[Abstract] |
| 17. | Erneux, C., Van Sande, J., Miot, F., Cochaux, P., Decoster, C., and Dumont, J. E. (1985) Mol. Cell. Endocrinol. 43, 123-134[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Martin, S. C., and Shuttleworth, T. J. (1994) FEBS Lett. 352, 32-36[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Shuttleworth, T. J. (1994) Cell Calcium 15, 457-466[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Sunahara, R. K., Dessauer, C. W., and Gilman, A. G. (1996) Annu. Rev. Pharmacol. Toxicol. 36, 461-480[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Thastrup, O. (1990) Agents Actions 29, 8-15[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Choi, E-J.,
Wong, S. T.,
Hinds, T. R.,
and Storm, D. R.
(1992)
J. Biol. Chem.
267,
12440-12442 |
| 23. |
Chiono, M.,
Mahey, R.,
Tate, G.,
and Cooper, D. M. F.
(1995)
J. Biol. Chem.
270,
1149-1155 |
| 24. | Burnay, M. M., Vallotton, M. B., Capponi, A. M., and Rossier, M. F. (1998) Biochem. J. 330, 21-27 |
| 25. |
Watson, E. L.,
Wu, Z.,
Jacobson, K. L.,
Storm, D. R.,
Singh, J. C.,
and Ott, S. M.
(1998)
Am. J. Physiol.
274,
C557-C565 |
This article has been cited by other articles:
![]() |
A. B. Parekh Ca2+ microdomains near plasma membrane Ca2+ channels: impact on cell function J. Physiol., July 1, 2008; 586(13): 3043 - 3054. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kolsch, P. G. Charest, and R. A. Firtel The regulation of cell motility and chemotaxis by phospholipid signaling J. Cell Sci., March 1, 2008; 121(5): 551 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Borges, S. Lindstrom, C. Walters, A. Warrier, and M. Wilson Discrete influx events refill depleted Ca2+ stores in a chick retinal neuron J. Physiol., January 15, 2008; 586(2): 605 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Willoughby and D. M. F. Cooper Organization and Ca2+ Regulation of Adenylyl Cyclases in cAMP Microdomains Physiol Rev, July 1, 2007; 87(3): 965 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Maia, C. A. Culver, and S. M. Laster Evidence against Calcium as a Mediator of Mitochondrial Dysfunction during Apoptosis Induced by Arachidonic Acid and Other Free Fatty Acids J. Immunol., November 1, 2006; 177(9): 6398 - 6404. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Singaravelu, C. Lohr, and J. W. Deitmer Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes. J. Neurosci., September 13, 2006; 26(37): 9579 - 9592. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. L. Martin and D. M. F. Cooper Capacitative and 1-Oleyl-2-acetyl-sn-glycerol-Activated Ca2+ Entry Distinguished Using Adenylyl Cyclase Type 8 Mol. Pharmacol., August 1, 2006; 70(2): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zur Nieden and J. W. Deitmer The Role of Metabotropic Glutamate Receptors for the Generation of Calcium Oscillations in Rat Hippocampal Astrocytes In Situ Cereb Cortex, May 1, 2006; 16(5): 676 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Mignen, C. Brink, A. Enfissi, A. Nadkarni, T. J. Shuttleworth, D. R. Giovannucci, and T. Capiod Carboxyamidotriazole-induced inhibition of mitochondrial calcium import blocks capacitative calcium entry and cell proliferation in HEK-293 cells J. Cell Sci., December 1, 2005; 118(23): 5615 - 5623. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Dyer, Y. Liu, I. P. de la Huerga, and C. W. Taylor Long Lasting Inhibition of Adenylyl Cyclase Selectively Mediated by Inositol 1,4,5-Trisphosphate-evoked Calcium Release J. Biol. Chem., March 11, 2005; 280(10): 8936 - 8944. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Shuttleworth, J. L. Thompson, and O. Mignen ARC Channels: A Novel Pathway for Receptor-Activated Calcium Entry Physiology, December 1, 2004; 19(6): 355 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wicher, S. Messutat, C. Lavialle, and B. Lapied A New Regulation of Non-capacitative Calcium Entry in Insect Pacemaker Neurosecretory Neurons: INVOLVEMENT OF ARACHIDONIC ACID, NO-GUANYLYL CYCLASE/cGMP, AND cAMP J. Biol. Chem., November 26, 2004; 279(48): 50410 - 50419. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Goraya, N. Masada, A. Ciruela, and D. M. F. Cooper Sustained Entry of Ca2+ Is Required to Activate Ca2+-Calmodulin-dependent Phosphodiesterase 1A J. Biol. Chem., September 24, 2004; 279(39): 40494 - 40504. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, Z. Liu, S. Chuai, and X. Shen Phospholipase C and phosphatidylinositol 3-kinase signaling are involved in the exogenous arachidonic acid-stimulated respiratory burst in human neutrophils J. Leukoc. Biol., September 1, 2003; 74(3): 428 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Tribe, P. Moriarty, A. Dalrymple, A. A. Hassoni, and L. Poston Interleukin-1{beta} Induces Calcium Transients and Enhances Basal and Store Operated Calcium Entry in Human Myometrial Smooth Muscle Biol Reprod, May 1, 2003; 68(5): 1842 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Szabadkai, A. M. Simoni, and R. Rizzuto Mitochondrial Ca2+ Uptake Requires Sustained Ca2+ Release from the Endoplasmic Reticulum J. Biol. Chem., April 18, 2003; 278(17): 15153 - 15161. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Smani, S. I. Zakharov, E. Leno, P. Csutora, E. S. Trepakova, and V. M. Bolotina Ca2+-independent Phospholipase A2 Is a Novel Determinant of Store-operated Ca2+ Entry J. Biol. Chem., March 28, 2003; 278(14): 11909 - 11915. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Mignen, J. L. Thompson, and T. J. Shuttleworth Ca2+ Selectivity and Fatty Acid Specificity of the Noncapacitative, Arachidonate-regulated Ca2+ (ARC) Channels J. Biol. Chem., March 14, 2003; 278(12): 10174 - 10181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Monteilh-Zoller, M. C. Hermosura, M. J.S. Nadler, A. M. Scharenberg, R. Penner, and A. Fleig TRPM7 Provides an Ion Channel Mechanism for Cellular Entry of Trace Metal Ions J. Gen. Physiol., December 30, 2002; 121(1): 49 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Bootman, P. Lipp, and M. J. Berridge The organisation and functions of local Ca2+ signals J. Cell Sci., March 8, 2002; 114(12): 2213 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Smith, C. Gu, K. A. Fagan, B. Hu, and D. M. F. Cooper Residence of Adenylyl Cyclase Type 8 in Caveolae Is Necessary but Not Sufficient for Regulation by Capacitative Ca2+ Entry J. Biol. Chem., February 15, 2002; 277(8): 6025 - 6031. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Mignen and T. J. Shuttleworth IARC, a Novel Arachidonate-regulated, Noncapacitative Ca2+ Entry Channel J. Biol. Chem., March 24, 2000; 275(13): 9114 - 9119. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Osterhout and T. J. Shuttleworth A Ca2+-independent Activation of a Type IV Cytosolic Phospholipase A2 Underlies the Receptor Stimulation of Arachidonic Acid-dependent Noncapacitative Calcium Entry J. Biol. Chem., March 10, 2000; 275(11): 8248 - 8254. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Fagan, K. E. Smith, and D. M. F. Cooper Regulation of the Ca2+-inhibitable Adenylyl Cyclase Type VI by Capacitative Ca2+ Entry Requires Localization in Cholesterol-rich Domains J. Biol. Chem., August 18, 2000; 275(34): 26530 - 26537. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Fagan, R. A. Graf, S. Tolman, J. Schaack, and D. M. F. Cooper Regulation of a Ca2+-sensitive Adenylyl Cyclase in an Excitable Cell. ROLE OF VOLTAGE-GATED VERSUS CAPACITATIVE Ca2+ ENTRY J. Biol. Chem., |